Andere Kunden interessierten sich auch für
![Diffuse Lung Diseases]( "Diffuse Lung Diseases")
Diffuse Lung Diseases168,99 €![Histological Typing of Lung and Pleural Tumours]( "Histological Typing of Lung and Pleural Tumours")
Histological Typing of Lung and Pleural Tumours67,99 €![ABC of Lung Cancer]( "ABC of Lung Cancer")
ABC of Lung Cancer51,99 €![Lung Cancer]( "Lung Cancer")
Lung Cancer39,99 €![Progress and Perspective in the Treatment of Lung Cancer]( "Progress and Perspective in the Treatment of Lung Cancer")
Progress and Perspective in the Treatment of Lung Cancer116,99 €![Bird Keeping as a Source of Lung Cancer and Other Human Diseases]( "Bird Keeping as a Source of Lung Cancer and Other Human Diseases")
Bird Keeping as a Source of Lung Cancer and Other Human Diseases77,99 €![Cancer Imaging]( "Cancer Imaging")
Cancer Imaging203,99 €
Lung cancer is the leading cause of cancer-related death among men and women in the U.S. and worldwide. For many decades, lung cancer was the sole cancer among the deadly four without an evidence-based screening method for decreasing mortality. This changed in November 2011, when findings from the National Lung Cancer Screening Trial showed low-dose lung CT screening was more efficacious in reducing deaths in high-risk individuals than conventional radiography. As such, an ever-increasing number of health organizations now recommend this screening protocol.
Lung Cancer Screening by Mark Parker and esteemed VCU Health colleagues, fulfills the dire need for a comprehensive guide explaining the crucial aspects of lung cancer screenings. The first two chapters lay a foundation with discussion of lung cancer epidemiology and risk factors beyond cigarette smoking. Subsequent chapters cover the fundamentals, with clinical pearls on setting up a successful lung cancer screening program, patient eligibility criteria, imaging variances of tumors in the lungs, screening pros and cons, and interpreting/reporting screening results.
- The evolution and future of lung cancer screenings
- Detection and management of unexpected incidental pulmonary and non-pulmonary findings
- Discussion of test cases utilizing the Lung-RADSTM risk-stratifying system for low-dose chest CT screenings
- Benefits and potential harms associated with mass lung cancer screening programs including false positive, false negative, and over-diagnosis rates
This state-of-the-art guide is essential reading for radiologists, oncologists, pulmonologists, and internists. It is a must-have bookshelf reference for hospital radiology and oncology departments, in particular for those setting up new lung cancer screening programs.
Lung Cancer Screening by Mark Parker and esteemed VCU Health colleagues, fulfills the dire need for a comprehensive guide explaining the crucial aspects of lung cancer screenings. The first two chapters lay a foundation with discussion of lung cancer epidemiology and risk factors beyond cigarette smoking. Subsequent chapters cover the fundamentals, with clinical pearls on setting up a successful lung cancer screening program, patient eligibility criteria, imaging variances of tumors in the lungs, screening pros and cons, and interpreting/reporting screening results.
- The evolution and future of lung cancer screenings
- Detection and management of unexpected incidental pulmonary and non-pulmonary findings
- Discussion of test cases utilizing the Lung-RADSTM risk-stratifying system for low-dose chest CT screenings
- Benefits and potential harms associated with mass lung cancer screening programs including false positive, false negative, and over-diagnosis rates
This state-of-the-art guide is essential reading for radiologists, oncologists, pulmonologists, and internists. It is a must-have bookshelf reference for hospital radiology and oncology departments, in particular for those setting up new lung cancer screening programs.